RxDoctor Payments Data

Cecilia Davis

Nurse Practitioner · Austin, TXNPI 1457825747

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $255,815 of the $261,658 with a category attached, or 97.8%. AbbVie accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $74,702 and has fallen 65.9% since, to $25,452 in 2025. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$261,658in general payments, 2019–2025

Across 253 payments — averaging $1034.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$261K
  • Galderma Laboratories, L.p.$344
  • Merz North America, Inc.$139

What the payments were for

  • Speaking & faculty fees$255,81598%
  • Travel & lodging$2,5101%
  • Food & beverage$3,3331%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)234$261,175
Galderma Laboratories, L.p.12$344
Merz North America, Inc.7$139

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$261,658 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas →

Other nurse practitioner in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →